Literature DB >> 9772312

Campylobacter jejuni as a cause of traveler's diarrhea: clinical features and antimicrobial susceptibility.

F Gallardo1, J Gascón, J Ruiz, M Corachan, M Jimenez de Anta, J Vila.   

Abstract

Traveler's diarrhea is the most common health problem of international travelers. Although enterotoxigenic Escherichia coli seems to be the most frequent cause of traveler's diarrhea, many other microorganisms, such as Campylobacter jejuni, may cause this infectious disease. Campylobacter jejuni is recognized as a leading cause of enteritis in humans both in developing and in developed countries. However, a few reports on the incidence and antimicrobial resistance of Campylobacter spp. as a cause of traveler's diarrhea have been published. The limited data on the treatment of C. jejuni infections suggest that ciprofloxacin may shorten the duration of symptoms. However, treatment failure associated with the emergence of quinolone-resistant strains of C. jejuni has been documented. The purpose of this study was to determine the prevalence of C. jejuni associated with traveler's diarrhea and to analyze the geographic distribution as well as the clinical features and susceptibility to antibiotics.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9772312     DOI: 10.1111/j.1708-8305.1998.tb00451.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  9 in total

1.  In vitro activity of rifaximin against enteropathogens producing traveler's diarrhea.

Authors:  J M Sierra; J Ruiz; M M Navia; M Vargas; J Vila
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Campylobacter jejuni is not an important pathogen as a cause of diarrhea in US travelers to Mexico.

Authors:  Nicolas A Villa; Pablo C Okhuysen; Jose Flores-Figueroa; Zhi-Dong Jiang; Jaime Belkind-Gerson; Mercedes Paredes; Jamal A Mohamed; Parvathy Nair; Lily Carlin; Herbert L DuPont
Journal:  J Travel Med       Date:  2010-11-22       Impact factor: 8.490

3.  Expression of Escherichia coli araE and modified lacY genes in Campylobacter jejuni is not sufficient for arabinose transport.

Authors:  Amritha Ramesh; Naomi Ikeda; Sona Rubinchik; Andrey V Karlyshev
Journal:  Access Microbiol       Date:  2019-07-16

4.  Travellers' diarrhea in children.

Authors:  Pierre J Plourde
Journal:  Paediatr Child Health       Date:  2003-02       Impact factor: 2.253

Review 5.  Diagnosis and treatment of bacterial diarrhea.

Authors:  James V Lawler; Mark R Wallace
Journal:  Curr Gastroenterol Rep       Date:  2003-08

6.  Quinolone and macrolide resistance in Campylobacter jejuni and C. coli: resistance mechanisms and trends in human isolates.

Authors:  J Engberg; F M Aarestrup; D E Taylor; P Gerner-Smidt; I Nachamkin
Journal:  Emerg Infect Dis       Date:  2001 Jan-Feb       Impact factor: 6.883

Review 7.  Human campylobacteriosis in developing countries.

Authors:  Akitoye O Coker; Raphael D Isokpehi; Bolaji N Thomas; Kehinde O Amisu; C Larry Obi
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

Review 8.  Acute Bacterial Gastroenteritis.

Authors:  James M Fleckenstein; F Matthew Kuhlmann; Alaullah Sheikh
Journal:  Gastroenterol Clin North Am       Date:  2021-04-23       Impact factor: 3.806

9.  Post-infectious IBS: Defining its clinical features and prognosis using an internet-based survey.

Authors:  Tim Card; Paul Enck; Giovanni Barbara; Guy Ee Boeckxstaens; Javier Santos; Fernando Azpiroz; Fermin Mearin; Qasim Aziz; John Marshall; Robin Spiller
Journal:  United European Gastroenterol J       Date:  2018-05-23       Impact factor: 4.623

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.